After receiving the COVID-19 vaccine, is it safe to see friends and family?
FOX News,
In the nearly yearlong battle against the novel coronavirus, hopes of ending the pandemic are riding with the development of…
In the nearly yearlong battle against the novel coronavirus, hopes of ending the pandemic are riding with the development of…
Different vaccines are now available in various countries. In the United States, vaccines need approval from the Food and Drug…
LUXEMBURG – Neben dem Vakzin von Biontech/Pfizer ist nun auch der Impfstoff von Moderna zugelassen.
_.
Il ne faut pas confondre vaccination et transmission. Comme le répètent le Premier ministre et le ministre de la Santé lors de…
Help for left-handed docs, prioritizing vaccination for HF patients, remote follow-up care for low-risk acute MI, and more.
Die Briten wollen die zweite Impfdosis verzögern, um schneller voranzukommen. Hierzulande soll das nicht kommen.
Australia’s COVID vaccine rollout will now begin in mid- to late February. Vaccination will commence with workers dealing with…
To date, more than 89 million cases of Covid-19 have been confirmed worldwide, with more than 1.9 million global deaths.
La campagne de vaccination a commencé en Suisse avec le vaccin de Pfizer pour les personnes les plus à risque.
In the past couple of weeks, experts and pundits have debated a big question surrounding the rollout of the Covid-19 vaccines…
Tribune : Commençons par une actualisation de nos connaissances sur les vaccins anti-covid à la lumière des publications très réc…
Australia's COVID-19 vaccine rollout will now begin in mid or late February. Vaccination will commence with workers dealing…
Research Centers of America (“RCA”), a CenExel Center of Excellence, joined nearly 100 other clinical research facilities…
The MHRA has approved Moderna's coronavirus vaccine. It is the regulator's third COVID-19 vaccine approval after Pfizer/BioNTech…
Powerful data on safety and efficacy published in New England Journal of Medicine HOLLYWOOD, Fla.
Powerful data on safety and efficacy published in New England Journal of Medicine HOLLYWOOD, Fla.
HOLLYWOOD, Fla., Jan. 7, 2021 /PRNewswire/ -- Research Centers of America (" RCA "), a CenExel Center of Excellence, joined…
HOLLYWOOD, Fla., Jan. 7, 2021 /PRNewswire/ -- Research Centers of America (""), a Center of Excellence, joined nearly 100 other…
Powerful data on safety and efficacy published in New England Journal of Medicine HOLLYWOOD, Fla.
Research Centers of America Expedite Broad Study on Moderna's COVID-19 Vaccine Powerful data on safety and efficacy published…
HOLLYWOOD, Fla., Jan. 7, 2021 /PRNewswire/ -- Research Centers of America ("RCA"), a CenExel Center of Excellence, joined…
HOLLYWOOD, Fla., Jan. 7, 2021 /PRNewswire/ -- Research Centers of America (" RCA "), a CenExel Center of Excellence, joined…
Powerful data on safety and efficacy published in New England Journal of Medicine HOLLYWOOD, Fla.
La situation sanitaire de l'Hexagone évolue fortement en ce début d'année. Les points clés à retenir avant les annonces…
Coronavirus The same reason views of this story will eventually peter out Just now · 7 min read A screenshot taken from my…
Vaccine rollouts in the UK, USA and Israel so far. Australia's COVID vaccine rollout will now begin in mid- to late February.
Ce jeudi, le Premier ministre, Jean Castex, voudra donner «de la visibilité», selon le porte-parole du gouvernement, Gabriel…
– By Mary-Louise McLaws, Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW Australia’s COVID…
Australia’s COVID vaccine rollout will now begin in mid- to late February. Vaccination will commence with workers dealing with…
Impfstoffe sollen die Pandemie beenden, nur wann? Wie gut schützen die Vakzinen und braucht es zwingend zwei Dosen? Sechs…
In the United States, some seniors and frontline workers have received their initial dosages of the COVID-19 vaccine and are…
/picture alliance, Laci Perenyi Amsterdam Die Europische Arzneimittelagentur (EMA) hat grnes Licht fr eine bedingte Zulassung…
Noticias destacadas de Salud En EE.UU. la desinformación está empezando a tener terribles consecuencias: un farmacéutico, que…
HealthDay News – The mRNA-1273 vaccine has 94.1% efficacy for preventing COVID-19 illness, according to a study published…
Die Arzneimittelagentur Ema spricht sich für die Zulassung des Impfstoffs der US-Firma Moderna in der EU aus.
Europe’s regulatory agency endorsed Moderna’s coronavirus vaccine for those 18 and up on Wednesday, paving the way for a second…
Noticias destacadas de Salud La Agencia Europea de Medicamentos (EMA) le dio luz verde al biológico producido por la empresa…
Conspiracy theories and misinformation about the coronavirus vaccine are still spreading on Facebook and Instagram, more than a…
Have stumbled outside the United States COVID-19 Immunization start gate. Three weeks after the Food and Drug Administration…
The United States has stumbled out of the COVID-19 vaccination starting gate. Over three weeks after the Food and Drug…
In Kürze erhält voraussichtlich ein weiterer Corona-Impfstoff die EU-Zulassung.
Similar efficacy seen in older study participants Peer-reviewed findings from the COVE trial showed the Moderna mRNA-1273…
There’s one thing that doctors, scientists, researchers and government officials all agree on: we don’t yet have enough Covid-19…
Parmi les différents laboratoires qui ont mis au point un vaccin contre la Covid-19, deux groupes pharmaceutiques tirent leur épi…
16:37 In der aktuellen Diskussion um die SARS-CoV-2 Impfstrategie möchte die DGfI darauf hinweisen, dass bereits die erste…
In der aktuellen Diskussion um die SARS-CoV-2 Impfstrategie möchte die DGfI darauf hinweisen, dass bereits die erste Impfung ab…
MONDAY, Jan. 4, 2021 (HealthDay News) — The mRNA-1273 vaccine has 94.1 percent efficacy for preventing COVID-19 illness…
Depuis le début de la campagne de vaccination contre la Covid-19, qui a débuté le 27 décembre dernier, de nombreuses questions…
В ході клінічних випробувань була досліджена дія однієї з нещодавно схвалених вакцин з ефективністю на рівні 95%, заснованих на м…
A published peer review agrees data from the collaboration between Moderna and the National Institute of Allergy and Infectious…
Phase-III-Studiendaten Die Phase-III-Studiendaten sind veröffentlicht: Der Corona-Impfstoff mRNA-1273 von Moderna ist ähnlich…
F ederal health officials leading the vaccine rollout are debating the idea of giving out as many first doses of two-dose…
Category: Family Medicine | Geriatrics | Gynecology | Infections | Internal Medicine | Critical Care | Emergency Medicine …
Jaimy Lee 'The idea of deferring dose 2 makes a lot of sense in the short term,' said Dr.
Salud Los expertos aseguran que la demora indica que el cuerpo está haciendo su trabajo y que los casos de COVID-19 en personas…
Jaimy Lee 'The idea of deferring dose 2 makes a lot of sense in the short term,' said Dr.
Deux firmes pharmaceutiques américaines dominent la course aux vaccins contre la Covid-19 : Moderna et Pfizer.
MONDAY, Jan. 4, 2021 -- The mRNA-1273 vaccine has 94.1 percent efficacy for preventing COVID-19 illness, according to a study…
MONDAY, Jan. 4, 2021 (HealthDay News) -- The mRNA-1273 vaccine has 94.1 percent efficacy for preventing COVID-19 illness…
Am 30.12.2020 erschien im »New England Journal of Medicine« die Publikation der Phase-III-Studie zum Impfstoff mRNA-1273 der US-F…
Mit mRNA-1273 des US-Unternehmens Moderna steht nach dem Impfstoff von Pfizer-BioNTech der nächste Impfstoff in der EU…
Mit mRNA-1273 des US-Unternehmens Moderna steht nach dem Impfstoff von Pfizer-BioNTech der nächste Impfstoff in der EU…
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study…
The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19…
As this new year is prone to pass entirely under the sign of COVID, it might be suitable to have as a first post one related to…
Le Dr Anthony S. Fauci, des National Institutes of Health n'est pas le seul à se poser la question : il revient, après la…
Robert M. Wachter is chair of the department of medicine at the University of California at San Francisco.
Los resultados preliminares del ensayo clínico en fase 3 muestra que el antídoto es seguro La vacuna en investigación conocida…
Results from the primary analysis of the ongoing phase 3 clinical trial demonstrate efficacy in preventing symptomatic COVID-19…
keystone-sda.ch 1/7 Der US-Pharmakonzern Moderna veröffentlicht Resultate der entscheidenden Phase der Impfstoff-Studie.
..G.M. La vacuna de Moderna muestra una eficacia del 94,1% en la fase 3 del ensayo en la cohorte de voluntarios de entre 18 y…
The results of a Phase 3 clinical trial evaluating the COVID-19 vaccine known as mRNA-1273 were published in the peer-reviewed…
WHAT: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (CO…
Results from the primary analysis of the ongoing phase 3 clinical trial demonstrate efficacy in preventing symptomatic COVID-19…
A healthcare worker in Oregon was hospitalized this week after suffering a severe allergic reaction to Moderna’s COVID-19…
Noticias destacadas de Salud Sin festejos, con fuertes restricciones de movimiento y reunión, y sin gente en las calles se…
Noticias destacadas de Salud Los resultados de la fase III del ensayo clínico, publicados en The New England Journal of Medicine…
Results from the primary analysis of the ongoing phase 3 clinical trial demonstrate efficacy in preventing symptomatic COVID-19…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
A flurry of headlines this week flooded social media, documenting a seemingly concerning case of COVID-19 in a San Diego nurse…
America did not sufficiently plan for how to get millions of people vaccinated.
The investigational vaccine known as mRNA-1273 was 94.1% effective in preventing symptomatic COVID-19, according to preliminary…
Reports of Covid-19 cases that appeared shortly after a single shot of a two-dose vaccine shouldn’t cause concern.
Reports of Covid-19 cases that appeared shortly after a single shot of a two-dose vaccine shouldn’t cause concern.
WHAT: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (CO…
BOSTON -- A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE…
WHAT: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (CO…
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, receives the Moderna COVID-19 vaccine…
Some family doctors in Britain said on Thursday that they would defy the government’s instructions to postpone patients…
Some family doctors in Britain said on Thursday that they would defy the government’s instructions to postpone patients…
Mercoledì 6 gennaio si terrà la riunione straordinaria dell’EMA che dovrebbe dare il via libera in Europa al vaccino anti COVID…
Cette analyse préliminaire des données de l'essai clinique en cours de phase III du vaccin de Moderna démontrent l'efficacité à…
Οι Ιατροί της Θεραπευτικής Κλινικής της Ιατρικής Σχολής του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών, Θεοδώρα Ψαλτοπούλου…
Τυχαιοποιημένη κλινική μελέτη φάσης 3 που πραγματοποιήθηκε σε 99 κέντρα στις Ηνωμένες Πολιτείες.
publicidade Os resultados da análise primária do ensaio clínico de fase da vacina Covid-19 da empresa de biotecnologia norte-amer…